tirzepatide atrial fibrillation and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism Epicardial Adipose Tissue as a
Description
Why GLP-1 Support Matters
Initially developed as a treatment for diabetes, the drug acts to stimulate the secretion of insulin, as well as suppress appetite by delaying gastric emptying and promoting satiety
Medicaid policies on GLP-1 weight loss medications differ significantly across states, with many requiring prior authorization or limiting coverage to diabetes treatment
Tips on injection sites, technique, storage, and safety
The U.K
